Content about Anticonvulsants

May 6, 2013
Pregnant women shouldn't use valproate drugs to prevent migraines, FDA warns

Pregnant women should not use migraine-prevention medications containing valproate sodium due to a higher risk of decreased IQ scores in children, the Food and Drug Administration warned.

January 15, 2013
Supernus appoints Victor Vaughn as SVP sales

A maker of drugs for epilepsy has appointed a new executive.

January 10, 2013
FDA approves Wockhardt epilepsy drug

The Food and Drug Administration has approved a generic epilepsy drug made by Wockhardt, the company said.

January 3, 2013
Greenstone launches authorized generic Dilantin Infatabs

Pfizer's generics division has launched an authorized generic drug for treating epilepsy.

December 28, 2012
FDA approves Mylan's generic Dilantin chewable tablets

Mylan on Friday announced that its subsidiary, Mylan Pharmaceuticals, has received final approval from the U.S. Food and Drug Administration for its phenytoin chewable tablets USP in the 50 mg strength.

August 14, 2012
Upsher-Smith buys British drug maker

Upsher-Smith Labs has finalized its purchase of a British company that makes drugs for central nervous system and inflammatory disorders, the former said Tuesday.

July 30, 2012
ReportersNotebook — Chain Pharmacy, 8/6/12

The Food and Drug Administration has approved Watson Pharmaceuticals’ Next Choice One Dose (levonorgestrel) tablets in the 1.5-mg strength.

July 26, 2012
Qualitest gets FDA OK for generic Keppra XR

Qualitest Pharmaceuticals announced that it has received approval from the Food and Drug Administration for its generic version of an epilepsy treatment.

July 24, 2012
Court rules in favor of Pfizer, Northwestern University in Lyrica patent case

A district court ruled in favor of Pfizer and Northwestern University in a patent infringement case relating to Lyrica (pregabalin).

July 23, 2012
Pfizer pain drug doesn't affect sperm production, study finds

A drug made by Pfizer for treating pain disorders doesn't affect men's reproductive functions, according to a new post-approval clinical study.

July 18, 2012
Mylan, Somaxon settle insomnia drug suit

Mylan has settled a patent litigation suit filed by Somaxon Pharmaceutical concerning an insomnia drug, Mylan said.

July 5, 2012
FDA approves generic version of Lyrica

The Food and Drug Administration has approved Lupin Pharmaceuticals' generic version of a drug used to treat pain and seizure disorders.

June 26, 2012
Supernus gets preliminary nod for epilepsy drug

The Food and Drug Administration has given tentative approval to Supernus Pharmaceuticals for a drug to treat epilepsy, the company said Tuesday.

June 21, 2012
FDA approves Lyrica for spinal pain

The Food and Drug Administration has approved a new indication for a Pfizer drug.

June 7, 2012
FDA approves GSK, XenoPort drug for shingles pain

The Food and Drug Administration has approved a drug made by GlaxoSmithKline and XenoPort for treating pain associated with shingles.

February 29, 2012
FDA approves Hi-Tech Pharmacal epilepsy drug

The Food and Drug Administration has approved a drug for epilepsy made by Hi-Tech Pharmacal, the drug maker said Wednesday.

January 12, 2012
Prasco to distribute authorized generic drug for seizures, pain

Prasco Labs will act as the distributor for an authorized generic version of a Shire anticonvulsant drug, the company said Thursday.

January 3, 2012
FDA approves Mylan epilepsy drug

The Food and Drug Administration has approved a drug for epilepsy made by Mylan, the drug maker said.

December 22, 2011
Amneal launches felbamate oral suspension

Amneal Pharmaceuticals has launched its generic version of a drug designed to treat seizures in adults and children with epilepsy.

October 24, 2011
FDA approves drug for severe epilepsy

The Food and Drug Administration has approved a new drug for treating a severe form of epilepsy, the agency said Monday.

October 10, 2011
Depomed launches shingles drug

Depomed has launched a new drug for treating shingles, the drug maker said Monday.

October 4, 2011
Amneal launches generic Felbatol

Amneal last month launched its version of an epilepsy treatment.

October 4, 2011
Report: Lupin stands to benefit from drug patent expiries

A wave of patent expirations over the next several years will open up a broad swath of drugs to generic competition, and India's Lupin Pharmaceuticals is looking to benefit, according to published reports.

October 4, 2011
Report: Supreme Court rejects Mylan appeal

Mylan must pay $77 million to four health insurers over allegations that it sought to control the market on ingredients used for two anti-anxiety medicines, according to published reports.

September 15, 2011
Lupin launches generic epilepsy drug

The Food and Drug Administration has approved a generic drug for epilepsy made by Lupin Pharmaceuticals, the drug maker said.

© 2013 Drug Store News. All Rights Reserved.